The Expression of β-Microseminoprotein but Not CRISP3 Is Reduced in Ovarian Cancer and Correlates to Survival.

Summary, in English

β-Microseminoprotein (MSMB) is an abundant protein in seminal plasma. Most of it is present as a free protein but a small part is bound to cysteine-rich secretory protein 3 (CRISP3) as a non-covalent complex. Even though their physiological function is unknown, both MSMB and CRISP3 have been ascribed roles in prostate carcinogenesis. Thus, several recent experimental studies indicate a tumor-suppressor role for MSMB. The present study was undertaken in order to evaluate, for the first time, the expression of MSMB and CRISP3 in ovaries and in ovarian tumors and to determine if their expression might indicate a role in ovarian tumor development.

• Författare: Rudi Henriksen; Åke Lundwall; Lene Udby; Per Fernlund
• Avdelning/ar: Urogynekologi och reproduktionsfarmakologi; Klinisk kemi, Malmö
• Publiceringsår: 2012
• Språk: Engelska
• Sidor: 3993-3999
• Publikation/Tidskrift/Serie: Anticancer research
• Volym: 32
• Issue: 9
• Länkar: http://www.ncbi.nlm.nih.gov/pubmed/22993349?dopt=Abstract
• Dokumenttyp: Artikel i tidskrift
• Förlag: International Institute of Cancer Research
• Ämne: Cancer and Oncology
• Nyckelord: CRISP3; beta-Microseminoprotein; immunohistochemistry; ovary; ovarian; cancer; survival
• Status: Published
• Forskningsgrupp: Urogynaecology and Reproductive Pharmacology; Clinical Chemistry, Malmö
• ISBN/ISSN/Övrigt: ISSN: 1791-7530